Ribavirin to Prevent RSV Pneumonia in Bone Marrow Transplant Patients

Stopped early · Phase 3

Conditions studied: Respiratory Syncytial Virus Infections

In brief

The purpose of this study is to test the safety and effectiveness of ribavirin, administered as an aerosol, in preventing progression of upper respiratory tract RSV infection to RSV pneumonia in bone marrow and peripheral blood transplant recipients.

Key facts

Study ID
NCT00031473
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
People needed
90
Starts
1997-11-01
Expected to finish
2003-03-01
Last updated by the study team
2010-08-27

Who can join

Age: 5 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.